Santen has announced that the European Commission has granted market authorisation for Ryjunea, a low-dose atropine eye drop ...

Birmingham spin-out Linear Diagnostics has secured £1m funding to advance a rapid test for sexually transmitted infections ...

Sogroya acts as a replacement for endogenous growth hormone and is administered once a week to support growth in children ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

Flip feasibility: from capacity and capability to human realities True feasibility begins with understanding the patient.

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in ...

Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines ...

The National Institute for Health and Care Excellence (NICE) has recommended FILSPARI (sparsentan) for use in the NHS in ...

With over 55 million people worldwide living with dementia, Oxford Brain Diagnostics (OBD) is set to revolutionise early ...

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share ...